Taken together, our results indicate that BAG3 is a potential modulator of the ALP, and therapeutic interventions targeting BAG3 may be sufficient to rescue dysfunction of the ALP seen in several neurodegenerative diseases with proteinaceous inclusions [10, 67]. The gene discussed is BAG3; the disease is neurodegenerative disease.